MOSCOW (Sputnik) — WADA noted that the organization would review the reasoning of ITF decision and decide whether or not to use the right of appeal to the Court of Arbitration for Sport (CAS).
"WADA acknowledges the decision issued [Wednesday] by the International Tennis Federation’s (ITF) Independent Tribunal which found that Maria Sharapova committed an Anti-Doping Rule Violation (ADRV) for the use of banned substance Meldonium, and that, as a consequence, a period of ineligibility of two (2) years has been imposed, commencing on 26 January 2016," WADA said in a statement issued Wednesday.
Sharapova, 29, was suspended in March after she admitted she had tested positive for meldonium, which is a metabolic modulator included in WADA Prohibited List, at the Australian Open in January.
